We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN DIEGO, March 21, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that, based upon the final vote count certified by the independent inspector of elections for...
Eiger to Participate in Cowen & Company 2016 Health Care Conference PR Newswire PALO ALTO, Calif., Feb. 29, 2016 PALO ALTO, Calif., Feb. 29, 2016 /PRNewswire/ -- Eiger BioPharmaceuticals...
SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today it has set a date for a special meeting of its stockholders to vote on matters related to the...
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Celladon Corporation (NASDAQ: CLDN) breached their fiduciary duties in...
--Celladon-Eiger Proposed Merger Creates a Biopharmaceutical Company With Diverse Portfolio of Four Novel Drug Development Programs Addressing Orphan Diseases-- --Concurrent Financing of...
Law Offices of Howard G. Smith reminds investors of the August 31,2015 lead plaintiff deadline in the class action lawsuit filed on behalf of a class comprising purchasers of the...
Law Offices of Howard G. Smith announces that a class action has been filed on behalf of purchasers of the securities Celladon Corporation (“Celladon” or the “Company”) (NASDAQ:CLDN), who...
Glancy Prongay & Murray LLP (“GPM”) announces the filing of a class action lawsuit on behalf of investors of Celladon Corporation (“Celladon” or the “Company”) (NASDAQ:CLDN), who...
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Celladon Corporation (“Celladon”...
CELLADON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Celladon Corporation To Contact The Firm PR Newswire NEW YORK, Aug...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions